Health leaders have issued a warning that Donald Trump’s push to increase NHS spending on medicines could lead to job losses and extended patient wait times. The NHS Confederation and NHS Providers, representing various health organizations, expressed concerns that the budget for this year did not account for costs related to redundancies, strikes, and increased medicine expenses. The potential impact of a proposed 25% rise in drug “value for money” thresholds could result in a significant shortfall in the NHS budget, causing delays in patient treatment.
US President Donald Trump’s threat to impose tariffs on drug imports from UK companies if the NHS does not agree to higher prices has led pharmaceutical giants to reconsider investing in the UK due to the low drug prices negotiated by the NHS. The chief executive of NHS Providers, Daniel Elkeles, highlighted the dilemma faced by the NHS in either balancing the books or facing deficits that could jeopardize services and waiting lists. Similarly, the chief executive of the NHS Confederation, Matthew Taylor, emphasized the risks posed by unanticipated redundancy costs, higher drug prices, and potential industrial action on meeting key waiting time targets and broader NHS reforms.
Leaders within the NHS estimate that a potential deal with the US regarding increased medicine prices could cost the NHS approximately £1.5 billion this year, adding to existing commitments such as £1 billion for staff redundancy payouts. The cumulative funding shortfall of up to £3 billion could result in longer wait times for patients and potential rationing of certain care services. The financial strain may force trusts to prioritize essential services over others, impacting the quality of care provided.
The upcoming UK autumn budget announcement by Chancellor Rachel Reeves will shed light on the government’s financial commitments, including those related to healthcare. Ongoing discussions between Health Secretary Wes Streeting and the Treasury aim to address the challenges faced by the NHS in light of potential funding gaps and increasing costs.
NHS data reveals a growing strain on resources, with acute hospital trusts in England experiencing a 5.8% increase in activity between 2024 and 2025. Despite a 3% rise in costs, overall productivity improved by 2.7%. However, the backlog in routine hospital treatments has shown little progress, with waiting lists reaching 7.41 million patients in August. The recent trends suggest that the NHS’s recovery is at a critical juncture, requiring careful financial planning and support to sustain services and meet growing demands.
Overall, the NHS is navigating financial challenges and resource constraints while striving to maintain service quality and meet patient needs. The government’s commitment to funding the NHS adequately and driving necessary reforms will play a crucial role in ensuring the sustainability and effectiveness of the healthcare system in the years to come.